Hemolysis Agent for Blood Cell Analyzer Market will reach USD 914.4 Million by 2028
The global Hemolysis Agent for Blood Cell Analyzer Market is estimated to reach USD 914.4 Million by 2028, according to a new report by Reports and Data. This can be mainly associated with the increasing number of age-related ailments such as liver, kidney, and heart along with an increase in the aging population worldwide. Lead poisoning and sickle cell disease are the reason for increased clinical testing in labs in various regions, which leads to the predominance of blood-related disorders such as hereditary spherocytosis, identification of abnormal hemoglobin’s, cytochemistries on blood and bone marrow, and chronic granulomatous disease. These factors are further expected to drive the market. Hemolysis agent for blood cell analyzer are frequently used in the determination of the health condition of a person by examining fluid body samples like blood and urine. The enhanced preference for preventive healthcare has encouraged the demand for early detection and tre...